New longitudinal research shows that Alzheimer’s disease blood biomarkers rise up to 95 percent faster in people with obesity than in those without. While baseline tests initially appeared lower due to blood dilution, long-term tracking revealed a significantly accelerated buildup of neurodegeneration and amyloid pathology.
